HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253,000 | +4.5% | 2,821 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $242,000 | +490.2% | 2,838 | +475.7% | 0.00% | – |
| Q1 2023 | $41,000 | -2.4% | 493 | -8.4% | 0.00% | – |
| Q4 2022 | $42,000 | -71.2% | 538 | -72.7% | 0.00% | -100.0% |
| Q3 2022 | $146,000 | +5.8% | 1,970 | -6.6% | 0.00% | 0.0% |
| Q2 2022 | $138,000 | -4.8% | 2,110 | -7.9% | 0.00% | 0.0% |
| Q1 2022 | $145,000 | +43.6% | 2,290 | +20.4% | 0.00% | – |
| Q4 2021 | $101,000 | -1.9% | 1,902 | +29.7% | 0.00% | – |
| Q3 2021 | $103,000 | +33.8% | 1,466 | +27.1% | 0.00% | – |
| Q2 2021 | $77,000 | -97.6% | 1,153 | -96.0% | 0.00% | -100.0% |
| Q1 2021 | $3,172,000 | +1.3% | 28,571 | +8.3% | 0.01% | -7.1% |
| Q4 2020 | $3,132,000 | +76.9% | 26,378 | +30.0% | 0.01% | +40.0% |
| Q3 2020 | $1,770,000 | +0.6% | 20,286 | +3.3% | 0.01% | 0.0% |
| Q2 2020 | $1,759,000 | +2449.3% | 19,635 | +2741.5% | 0.01% | – |
| Q1 2020 | $69,000 | -75.8% | 691 | -72.1% | 0.00% | -100.0% |
| Q4 2019 | $285,000 | -53.9% | 2,477 | -49.4% | 0.00% | -66.7% |
| Q3 2019 | $618,000 | -55.3% | 4,896 | -57.4% | 0.00% | -57.1% |
| Q2 2019 | $1,382,000 | -41.7% | 11,482 | -57.6% | 0.01% | -41.7% |
| Q1 2019 | $2,370,000 | -52.2% | 27,089 | -45.3% | 0.01% | -58.6% |
| Q4 2018 | $4,959,000 | -4.3% | 49,563 | +9.6% | 0.03% | +11.5% |
| Q3 2018 | $5,182,000 | +53.5% | 45,229 | +20.2% | 0.03% | +52.9% |
| Q2 2018 | $3,375,000 | +2968.2% | 37,630 | +2403.7% | 0.02% | +1600.0% |
| Q1 2018 | $110,000 | -20.3% | 1,503 | -36.9% | 0.00% | 0.0% |
| Q4 2017 | $138,000 | +22.1% | 2,383 | -5.6% | 0.00% | 0.0% |
| Q3 2017 | $113,000 | -44.1% | 2,524 | -50.5% | 0.00% | 0.0% |
| Q2 2017 | $202,000 | +88.8% | 5,104 | +94.4% | 0.00% | 0.0% |
| Q1 2017 | $107,000 | +8.1% | 2,626 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $99,000 | +2.1% | 2,626 | -2.3% | 0.00% | 0.0% |
| Q3 2016 | $97,000 | +24.4% | 2,689 | -0.6% | 0.00% | 0.0% |
| Q2 2016 | $78,000 | -3.7% | 2,706 | +16.9% | 0.00% | 0.0% |
| Q1 2016 | $81,000 | +8.0% | 2,315 | -0.8% | 0.00% | – |
| Q4 2015 | $75,000 | -21.1% | 2,334 | -20.7% | 0.00% | -100.0% |
| Q3 2015 | $95,000 | -25.2% | 2,943 | -4.5% | 0.00% | 0.0% |
| Q2 2015 | $127,000 | -9.9% | 3,081 | -1.9% | 0.00% | 0.0% |
| Q1 2015 | $141,000 | +12.8% | 3,141 | -5.7% | 0.00% | 0.0% |
| Q4 2014 | $125,000 | +9.6% | 3,330 | +1.8% | 0.00% | 0.0% |
| Q3 2014 | $114,000 | -25.0% | 3,270 | -24.0% | 0.00% | 0.0% |
| Q2 2014 | $152,000 | +20.6% | 4,304 | +11.3% | 0.00% | 0.0% |
| Q1 2014 | $126,000 | -31.5% | 3,867 | -11.6% | 0.00% | 0.0% |
| Q4 2013 | $184,000 | +116.5% | 4,374 | +106.2% | 0.00% | – |
| Q3 2013 | $85,000 | – | 2,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |